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Abstract
Purpose
To assess the differences in texture descriptors and optical properties of retinal tissue layers
in patients with multiple sclerosis (MS) and to evaluate their usefulness in the detection of
neurodegenerative changes using optical coherence tomography (OCT) image
segmentation.
Patients and Methods
38 patients with MS were examined using Stratus OCT. The raw macular OCT data were
exported and processed using OCTRIMA software. The enrolled eyes were divided into two
groups, based on the presence of optic neuritis (ON) in the history (MSON+ group, n = 36
and MSON- group, n = 31). Data of 29 eyes of 24 healthy subjects (H) were used as con-
trols. A total of seven intraretinal layers were segmented and thickness as well as optical
parameters such as contrast, fractal dimension, layer index and total reflectance were mea-
sured. Mixed-model ANOVA analysis was used for statistical comparisons.
Results
Significant thinning of the retinal nerve fiber layer (RNFL), ganglion cell/inner plexiform layer
complex (GCL+IPL) and ganglion cell complex (GCC, RNFL+GCL+IPL) was observed
between study groups in all comparisons. Significant difference was found in contrast in the
RNFL, GCL+IPL, GCC, inner nuclear layer (INL) and outer plexiform layer when comparing
MSON+ to the other groups. Higher fractal dimension values were observed in GCL+IPL
and INL layers when comparing H vs. MSON+ groups. A significant difference was found in
layer index in the RNFL, GCL+IPL and GCC layers in all comparisons. A significant differ-
ence was observed in total reflectance in the RNFL, GCL+IPL and GCC layers between the
three examination groups.
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Conclusion
Texture and optical properties of the retinal tissue undergo pronounced changes in MS
even without optic neuritis. Our results may help to further improve the diagnostic efficacy of
OCT in MS and neurodegeneration.
Introduction
Multiple sclerosis (MS) is a neurodegenerative disorder, a chronic inflammatory process that
affects the central nervous system (CNS) by the demyelination of axons of the brain and spinal
cord. It is the most common disease of the CNS that causes permanent disability in young
adults. [1] The non-myelinated parts of the axons of the retinal ganglion cells, the retinal nerve
fiber layer (RNFL) provides an optimal opportunity to examine the neuronal loss caused by
demyelination.
Optical coherence tomography (OCT) is a non-invasive, non-contact, high-resolution
imaging modality that is capable of capturing cross-sectional images of the retina. [2] It is
based on the optical reflectance differences of the analyzed tissue and thus it may be applied in
the detection of pathological retinal changes. [3] OCT technology has gained very wide use in
ophthalmology and it is stipulated that it is one of the most frequently used decision making
techniques in the field. [4] The use of custom-built algorithms for the segmentation of retinal
OCT images may enable the detection and follow-up of early neural loss in patients with MS.
[5–8] It has also been postulated that the inner nuclear layer (INL) is possibly also involved in
the pathological processes in MS, with different observations describing microcystic edema of
the INL and also the thickness changes of the INL. [9, 10]
Although thickness differences may discern regions with signs of retinal disease from nor-
mal regions, differences in texture descriptors of normal and abnormal retinal tissue may also
provide additional information of disease development. In fact, the appropriateness of texture
to classify tissues in OCT images has been shown in previous studies. [11] By analyzing the
spatial arrangement of color or intensities in an image or selected region of interest (ROI), the
image irregularities can be measured. Consequently, texture features, such as contrast and frac-
tal dimension could be analyzed for the macula and each intraretinal layer. The fractal dimen-
sion (FD) of a profile or surface is a roughness measure regarded as a local property of the
system with higher values indicating rougher surface. [12] There are different methods to
determine the FD. The typical conventional approach used to calculate the fractal dimension
of an image is the box-counting method but the power spectrum method is demonstrated to be
more robust. [13, 14]
Finally, as mentioned above, the most common parameter investigated during the OCT
examination is retinal thickness. In reality, reflectance is the direct measurement from which
thickness is calculated in OCT systems. The human retina is an almost transparent tissue that
only reflects about 1% of the incident light. [15] Retinal tissue is characterized by many small
random fluctuations in refractive index caused by the ultrastructure of the tissue. [16] As a con-
sequence, incident light on tissue is deflected or scattered off this structure. Therefore, differ-
ences in optical properties of normal and abnormal retinal tissue may also provide additional
information of disease development in pathological eyes allowing OCT technology to be used
for quantitative analysis of tissue optical properties. [17–19] Accordingly, Bizheva et al have
shown previously that optical properties of the retina may change due to their metabolic activ-
ity. They were using optical coherence tomography for this purpose and named the method
Retinal Texture and Optical Property Changes in MS
PLOSONE | DOI:10.1371/journal.pone.0143711 November 30, 2015 2 / 20
(unrestricted grant to the University of Miami, DCD));
Hungarian Academy of Sciences, Zsigmond Diabetes
Fund (http://mta.hu/english/ (GMS)); Hungarian
Scholarship Fund, Eötvös Scholarship (http://www.
scholarship.hu/ (GMS)). The funders had no role in
study design, data collection and analysis, decision to
publish, or preparation of the manuscript. This work
was also supported by Helen Keller Foundation for
Research and Education (http://www.
helenkellerfoundation.org/ (GMS)). Also, the authors
declare that this funder also had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have read the
journal’s policy and the authors of this manuscript
have the following financial competing interests: The
University of Miami and Dr. Cabrera DeBuc hold a
patent used in the study and have the potential for
financial benefit from its future commercialization.
The data of the patent: U.S. Patent No. 8 868 155;
Name: System and method for early detection of
diabetic retinopathy using optical coherence
tomography; Pub. No. : WO/2010/080576.
International Application No. :PCT/US2009/068653.
This patent does not alter the authors' adherence to
all PLOS ONE policies on sharing data and materials,
as detailed online in the PLOS One’s guide for
authors. There are no restrictions on sharing of data
and/or materials. All the other authors have nothing to
declare. All authors declared that no other competing
interests exist.
optophysiology. [20] Huang et al. have shown the early changes of reflectance of the RNFL in a
rat model of glaucoma preceding the pathological changes in the retina. [21] We have shown
previously that diabetes not only causes thinning of the inner retinal layers, but also reduces
the amplitude of the back-reflected signal from these layers. [22, 23] Consequently, diagnostic
predictors based on reflectance changes may be of interest in multiple sclerosis as well where
pathological processes of the inner retina have been well described previously.
In this study, the differences in texture and optical properties of the retinal tissue in patients
with MS compared to healthy subjects are evaluated using OCT image segmentation in order
to investigate their usefulness in the detection of retinal neurodegenerative changes. Significant
differences in the nerve fiber layer and the ganglion cell/plexiform layer complex are observed
in MS patients compared to healthy subjects and in eyes affected by optic neuritis compared to
those unaffected. Our findings may help to further improve the diagnostic efficacy of OCT in
MS and neurodegeneration.
Patients and Methods
Study Population and examinations
All participants were treated in accordance with the tenets of the Declaration of Helsinki. Insti-
tutional Review Board approval was obtained for all study protocols (Semmelweis University
Regional and Institutional Committee of Sciences and Research Ethics). Written informed con-
sent was obtained from all participants in this study. Thirty-eight patients with relapsing-
remitting multiple sclerosis were enrolled from the Department of Neurology of Semmelweis
University. The clinical data, including disease duration, medical treatment and the date of
MSON episodes was compiled as part of a complete neurological examination performed by a
board-certified neurologist. Based on the neurological, functional, elecrophysiological, radio-
logical and laboratory examinations, all ON episodes were diagnosed as MS associated ON and
all patients were meeting the revised McDonald criteria. [24] The control group (H) was made
of twenty-nine randomly selected eyes of twenty-four age-matched healthy controls.
Each subject underwent routine ophthalmic examination including best corrected visual
acuity measurement, applanation tonometry, critical flicker frequency assessment (CFF) and
slit-lamp examination. All study subjects were assessed by the same, expert and trained opera-
tor with a Stratus OCT device (Carl Zeiss Meditec Inc., Dublin, CA, USA) using the “macular
map protocol”, which consists of six fovea centered scan lines in radial directions, each having
a 6 mm transverse length. One study eye per each patient was selected randomly.
In order to ensure quality control of the OCT scans included and segmented in the study,
we used the scan quality factor (SQF) criteria in OCTRIMA for checking the scan variance
using the foveal center point thickness as reported previosuly [25] and also adapted the
OSCAR-IB system described by Tewarie at al. [26]
The scan quality factor (SQF) is based on the standard deviation calculation (in percent) of
the center point thickness (CPT) for the six radial line scans included in the OCTRIMA soft-
ware and is used to control the variability of measurements associated to image acquisition pit-
falls. A high standard deviation (>10% of center point thickness) means high variability,
usually due to patient movement or boundary line error, thus leading to incorrect center point
thickness values. [25, 27] We only included scans with a SQF = 1, indicating that the percent-
age standard deviation of the foveal center point was10%.
Furthermore, using the OSCAR-IB system the following details were observed and evaluated
on each set of scans to be included in the study: Obvious problems not covered by items below;
Sufficient OCT Signal (SS>6, [25]); Foveal centered scans (as a second pass of quality control);
Algorithm failure; Retinal pathology impairing the segmentation; Proper fundus illumination;
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andMeasurement beam placed centrally (no tilting of the B-scans). The exclusion criteria were
similar to those applied by Tewarie et al., including the following: (1) spherical or cylindrical cor-
rection higher than 3.0 diopters, (2) the presence of any media opacities (corneal pathologies, cat-
aract, floaters, etc.) (3) the presence of any retinal disease or optic neuropathy including
glaucoma, except ON, (4) intraocular pressure higher than 20 mmHg in the medical history, (5)
previous eye surgery, (6) amblyopia, (7) last MSON episode less than 6 months prior to enroll-
ment, (8) bad fixation cooperation during the OCT examination (e.g. due to nystagmus) and (9)
low signal strength of the OCT images (SS6). None of the patients were under fingolimod treat-
ment before and during the examination period. [28] As in previous TD-OCT studies [29–31]
where highly repeatable measurements have been obtained with signal intensity scores of at least
6 to 7, we excluded images with signal strength SS6 as we have previously shown this is the
threshold for repeatable segmentation analysis with OCTRIMA. [25]
The eligibility criteria for control subjects were best-corrected Snellen visual acuity of 20/20
and the lack of any ocular or systemic diseases, with good quality OCT scans as described above.
OCT image processing
The radial scans were exported and processed by a custom-built software (OCTRIMA) devel-
oped by Cabrera et al. [6]. This OCT image segmentation program is capable of segmenting 7
cellular layers of the retina based on their optical densities (see Fig 1): the RNFL, the ganglion
cell and inner plexiform layer complex (GCL+IPL), the INL, the outer plexiform layer (OPL),
the outer nuclear layer and inner photoreceptor segment (ONL+IS), outer photoreceptor seg-
ment (OS) and retinal pigment epithelium (RPE). [6] Because of the special arrangement of the
retinal structure below the foveal pit where the inner retinal layers are displaced concentrally,
Fig 1. Macular image segmentation results using OCTRIMA. (A) The image of a healthy macula scanned by Stratus OCT with the division of the macular
regions used for the analysis (foveolar region (a) with a diameter of 0.375 mm, foveal region (b) with a diameter of 1.85 mm; parafoveal region (c) with a
diameter of 2.85 mm and perifoveal region (d) with a diameter of 5.85 mm) (B) The same OCT scan processed with OCTRIMA. Abbreviations: Ch, choroid;
GCL+IPL, ganglion cell layer and inner plexiform layer complex; INL, inner nuclear layer; ONL+IS, combined outer nuclear layer and inner segment of
photoreceptors; OS, outer segment of photoreceptors; OPL, outer plexiform layer; RNFL, retinal nerve fiber layer; RPE, retinal pigment epithelial layer; V,
vitreous.
doi:10.1371/journal.pone.0143711.g001
Retinal Texture and Optical Property Changes in MS
PLOSONE | DOI:10.1371/journal.pone.0143711 November 30, 2015 4 / 20
the segmentation of the foveolar region was limited to the three outer retinal layers (ONL+IS,
OS, RPE).
The OCTRIMA software integrates a denoising and edge enhancement technique (also
removing the speckle noise) along with a segmentation algorithm. [6] In our previous works
the high repeatability and reproducibility of OCTRIMAmeasurements in healthy subjects was
found. The reproducibility was the highest for the thickness measurements of the ONL, gan-
glion cell complex (GCC, composed by the RNFL and GCL+IPL), GCL+IPL and RNFL, the
inter- and intraexaminer, intervisit variabilities being around the resolution of currently avail-
able OCT devices for all layers (<6 μm for all layers and all comparisons). [25] It is of note that
total retinal thickness is measured between the inner limiting membrane and the inner bound-
ary of the photoreceptor outer segment/RPE junction by this software. It is also important to
mention that ONL is a thin membrane, which contains both the external limiting membrane
and the inner segment of the photoreceptors. This layer cannot be visualized clearly in Stratus
OCT images which makes the segmentation of the inner segment more difficult. Thus, the seg-
mentation of this layer does not reflect the actual anatomic structure.
The eyes of the MS patients were divided into two study groups for further analyses. The
first group was composed of 36 eyes, which had MS-associated ON at least 6 months prior to
enrollment (MSON+). 31 eyes without ON episode (MSON-) in the history formed the second
group. The diagnosis of optic neuritis was based on the patient's medical history. An acute epi-
sode of MSON was defined by clinical symptoms such as decreased visual acuity developing in
few days, pain on eye movement, abnormal response on visual evoked potential examination
confirming prechiasmal lesion and decrease in the CFF. The CFF is a basic examination of
optic nerve function, and plays an important role in the diagnosis and also in the follow-up of
ON. Decreased CFF is a common characteristic of an acute ON episode, and it also can be
affected after the recovery both of which can help to establish the diagnosis of ON. In most
cases a good recovery was observed within 2–3 months. In the subjects with ON appearing as a
first symptom, routine MRI examinations showed characteristic signs of MS and confirmed
the diagnosis. Demographic and clinical characteristics including age, gender, duration of dis-
ease, elapsed time between the last MSON episode and OCT examination and best corrected
visual acuity are shown in Table 1.
Retinal layer thickness, texture and optical measurements on OCT
images
In order to evaluate the diagnostic power of optical properties and texture descriptors com-
pared to standard thickness measurements, mean thickness values per intraretinal layer were
Table 1. Descriptive statistics of the study participants.
Healthy group MSON- group MSON+ group
Number of eyes 29 31 36
Number of subjects (female/male) 24 (16/8) 25 (14/11) 26 (19/7)
Age(years, mean ±SD, [median]) 33 ± 9 [31] 34 ± 9 [35] 34 ± 9 [35]
BCVA (mean ±SD, [median]) 1.0 ± 0.00 [1.0] 1.0 ± 0.00 [1.0] 0.91 ± 0.25 [1.0]
Disease duration(months, mean ±SD [median]) N/A 71 ± 51 [48] 72 ± 51 [53]
Elapsed time between last MSON episode and examination date (months, mean ± SD [median]) N/A N/A 49 ± 38 [38]
Abbreviations: SD (standard deviation); H (Healthy subjects group); MSON- (eyes of patients with multiple sclerosis without optic neuritis in medical
history); MSON+ (eyes of patients with multiple sclerosis with optic neuritis in medical history); BCVA (best corrected visual acuity).
doi:10.1371/journal.pone.0143711.t001
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extracted by computation of the mean distance between the borders of each layer. We note that
we removed the noise first and then performed the processing so that noise effect could be nul-
lified. Therefore, all calculations were performed after removing the speckle noise from raw
OCT data using a complex diffusion filter. [6] We also note that factors extrinsic to the retina,
such as media opacity, poor focusing, and scanning pitfalls, were removed by taking the ratio
of the average reflectivity signal within the retina and each intraretinal layers and dividing it by
the average reflectivity signal from a reference layer. Accordingly, the analyses performed using
parameters based on optical properties and tissue descriptors considered mean reflectivity val-
ues that were calculated using reflectivity with normalization to the RPE reflectance (NRPE).
[32] The mean values were calculated to each layer across the six radial OCT scans. [33]
A method based on the power spectrum was used to calculate the fractal dimension in OCT
images. [14] Since the average power spectrum of an image obeys a power law scaling, the frac-
tal dimension was calculated from the power law detected in the graph of the power spectrum
as a function of the frequency in the Fourier transform of the OCT image (gray scale). In this
particular case, when the graph is plotted in a log-log scale the curve is approximately similar
to a straight line and the dimension is provided by the slope of the line.
The fast Fourier transform (FFT) was applied to the OCT reflectance’s profiles to obtain the
power spectrum as follows:
PðoÞ  ob ð1Þ
where P(ω) is the power spectrum with the frequency ω. β is the spectral exponent of the reflec-
tance profile. The Eq (1) can be converted into:
lnðPðoÞÞ  blnðoÞ ð2Þ
The fractal dimension is linked to the power-law exponent by the following relationship:
[14]
FD ¼ 5 b
2
ð3Þ
Therefore, the fractal dimension was evaluated from the slope β of a least-square regression
line fit to the data points in log-log plot of power spectrum. The fractal dimension was calcu-
lated for the reflectance profile within each intraretinal layer for each A-scan. The mean value
of the fractal dimension was calculated by averaging the fractal dimension measurements
across all A-scans in each macular region of each intraretinal layer. MATLAB software (The
Mathworks, Natick, MA) was used to perform the fractal dimension analysis using a custom-
built algorithm. Contrast measures were extracted by using second-order statistical texture
analysis.
Optical properties such as total reflectance and layer index has been described previously
and calculated as follows. [23, 33, 34] Total reflectance TRk was calculated by summarizing
reflectivity values of the elements in the column k of the selected ROI.
TRk ¼ MRk 
Hk
Dy
ð4Þ
whereMRk is the mean reflectance in the column k of the selected ROI,Hk is the local thickness
of ROI in the column of k, and Δy is the pixel resolution defined by the OCT device.
Retinal Texture and Optical Property Changes in MS
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Layer index LIk was defined as:
LIk ¼ MRk 
Hk
Isa
¼ 1
Nk
XNk
j¼1
Ij;k 
Hk
Isa
ð5Þ
whereMRk is the mean reflectance in the column k of the selected ROI,Hk is the local thickness
of ROI in the column of k. Isa is the reflectivity value representing the 99% of all recorded
reflectivity values in a given retinal OCT image.
It is worth to note that before the calculation of parameters related to reflectance values,
the lateral coordinates of the blood vessel shadows were obtained by the help of a blood vessel
shadowgram technique and were removed in each OCT image. [35] Following this, these
shadows were removed in each OCT image before calculating the values for reflectance.
Total reflectance values included average values of reflectance with normalization to the RPE
reflectance (NRPE). Average values of total reflectance per intraretinal layer were calculated.
Total reflectance values were converted to decibels (dB = 10 ×log10 [TR]). Layer index
parameter was based on the mean reflectance corrected to the thickness of the region of
interest and the 99% of the total reflectance of the scan (see details above and Eq 5). [18] All
calculated values were expressed in the foveolar, foveal, parafoveal and perifoveal regions
and also as a mean across all macular regions. (Fig 2.) In the foveolar region, the calculations
were limited to the outer retinal layers (OPL+IS, OS, RPE). For the analyses an additional
composite layer was defined, the GCC consisting of the RNFL and GCL+IPL layers with the
purpose to observe the changes of the whole ganglion cell with its proximal and distal
denrites.
Statistical analyses
In order to correct for inter-eye bias, mixed model ANOVA analysis was used for the compari-
son of thickness and optical parameters among the groups. Statistical analyses were performed
using the software package SPSS version 16 (SPSS Inc, Chicago, Illinois). A modified p value
(p<0.001) was considered as statistically significant.
Fig 2. Retinal scanning andmacular regions used in the study. (A) The fundus image of a healthy eye. The white arrows in the macula show the
locations of the OCT scans made. (B) The distribution of macular regions: foveolar region (a) with the diameter of 0.375 mm, foveal region (b) with a diameter
of 1.85 mm; parafoveal region (c) with a diameter of 2.85 mm and perifoveal region (d) with a diameter of 5.85 mm.
doi:10.1371/journal.pone.0143711.g002
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Results
Thickness
The thinning of the RNFL, GCL+IPL and also GCC was significant in all comparisons in each
macular region except the foveal region. In the foveal region significant difference was
observed in GCC between H, MSON- and MSON+ groups, in RNFL between H and MSON+,
and GCL+IPL in MSON+ compared to the others. (Table 2.)
Contrast
Significantly higher contrast values were observed in the MSON+ group compared to the H
and MSON- groups in the RNFL, GCL+IPL, INL, OPL and GCC layers, in the whole macular
region. A significant difference was found in the foveal region between MSON+ and the two
other groups in the GCL+IPL and GCC, similarly to the INL in the MSON+ versus the healthy
group. The GCL+IPL was significantly different between the three groups in the parafoveal
region, and so was the RNFL and GCC in the MSON+ vs. H comparison. The perifoveal region
showed a significant difference between the three groups in the RNFL, GCL+IPL and GCC lay-
ers. (Table 3.)
Fractal dimension
Fractal dimension was significantly higher in the MSON+ group compared to the H and
MSON- groups in the GCL+IPL and INL in the whole macular region, in the INL in the foveal
and in the GCL+IPL in the perifoveal regions. Also, a significant difference was found in the
OPL between the H and MSON- groups in the parafoveal region. There were no significant dif-
ferences found in any other layers in other comparisons. (Table 4.)
Layer index
The layer index values were significantly lower in the MSON- and MSON+ groups compared
to the healthy controls, and also in the MSON+ versus MSON- comparisons in the RNFL,
GCL+IPL and GCC in the whole macular, parafoveal and perifoveal regions. In the foveal
region the GCL+IPL was significantly thinner in MSON+ compared to the other two groups,
and the same was observed for the GCC in the MSON+ and H groups. (Table 5.)
Total reflectance
The total reflectance was found significantly different in the RNFL and GCC in both disease
groups in the whole macular, the parafoveal and perifoveal regions, and the same was true for
the GCL+IPL between the three groups in the parafoveal and perifoveal regions. In the foveal
region a significant difference was observed in GCL+ IPL in MSON+ compared to the other
groups, and also in the GCC complex for the comparison between the MSON+ and H groups.
(Table 6.)
Discussion
Optical coherence tomography has been used extensively to describe structural changes in the
retina. In case of patients with multiple sclerosis, significant changes of retinal structure were
previously described by histology and by Fourier-domain OCT (FD-OCT) image segmenta-
tion, not only in the inner, but also in the outer retinal layers. [36–39] Green et al. conducted
postmortem evaluations in 82 patients with MS. They found histological changes not only in
the ganglion cell layer but also in the inner nuclear layer, comprising the bipolar and amacrine
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Table 2. Distribution statistics of the thickness (μm) of intraretinal layers by study group, represented asmeans ±SD.
Thickness Healthy MSON- MSON+
H vs. MSON+ H vs. MSON- MSON+ vs MSON-
Across All Macular Regions
RNFL 38.16 ± 0.55 ‡ 35.44 ± 0.54 ‡ 32.32 ± 0.54 ‡
GCL+IPL 76.06 ± 1.44 ‡ 67.87 ± 1.40 ‡ 58.1 ± 1.40 ‡
GCC 114.23 ± 1.85 ‡ 103.28 ± 1.80 ‡ 90.45 ± 1.95 ‡
INL 35.19 ± 0.35 35.38 ± 0.35 35.26 ± 0.36
OPL 41.70 ± 0.58 * 41.58 ± 0.55 39.92 ± 0.59 *
ONL+IS 86.23 ± 1.21 * 88.20 ± 1.11 89.62 ± 1.19
OS 16.48 ± 0.59 16.58 ± 0.57 16.28 ± 0.62
RPE 13.15 ± 0.18 13.58 ± 0.17 13.21 ± 0.19
Foveolar Region
ONL+IS 123.55 ± 1.79 124.46 ± 1.65 123.57 ± 1.76
OS 26.02 ± 0.62 25.93 ± 0.60 25.21 ± 0.65
RPE 16.10 ± 0.30 16.57 ± 0.28 15.83 ± 0.31 *
Foveal Region
RNFL 12.42 ± 0.45 ‡ 10.60 ± 0.42 * 9.7 ± 0.45 *
GCL+IPL 51.59 ± 1.04 ‡ 47.51 ± 1.01 * 40.1 ± 1.10 ‡
GCC 63.92 ± 1.28 ‡ 58.07 ± 1.24 * 49.9 ± 1.34 ‡
INL 21.00 ± 0.36 20.82 ± 0.34 20.19 ± 0.37
OPL 62.35 ± 1.53 * 61.47 ± 1.44 56.34 ± 1.55 *
ONL+IS 99.45 ± 1.47 * 101.70 ± 1.37 104.43 ± 1.48
OS 18.45 ± 0.79 18.87 ± 0.77 18.73 ± 0.83
RPE 13.41 ± 0.25 13.86 ± 0.25 13.41 ± 0.27
Parafoveal Region
RNFL 34.35 ± 0.53 ‡ 31.92 ± 0.52‡ 28.96 ± 0.56 ‡
GCL+IPL 93.66 ± 1.86 ‡ 82.75 ± 1.81 ‡ 69.88 ± 1.97‡
GCC 128.03 ± 2.22‡ 114.62 ± 2.16‡ 98.92 ± 2.35‡
INL 39.93 ± 0.47 40.59 ± 0.45 40.48 ± 0.49
OPL 37.51 ± 0.53 37.26 ± 0.51 37.23 ± 0.55
ONL+IS 84.54 ± 1.40 * 86.87 ± 1.30 88.44 ± 1.39
OS 14.74 ± 0.72 15.17 ± 0.70 15.04 ± 0.76
RPE 12.64 ± 0.22 12.98 ± 0.21 12.64 ± 0.23
Perifoveal Region
RNFL 43.16 ± 0.69 ‡ 39.39 ± 0.68 ‡ 35.6 ± 0.73 ‡
GCL+IPL 66.28 ± 1.38 ‡ 58.68 ± 1.33 ‡ 50.68 ± 1.44 ‡
GCC 16.48 ± 0.59 ‡ 98.06 ± 1.79 ‡ 86.29 ± 1.95 ‡
INL 38.16 ± 0.55 33.19 ± 0.33 33.04 ± 0.36
OPL 76.06 ± 1.44 31.90 ± 0.27 31.56 ± 0.29
ONL+IS 35.19 ± 0.35 76.50 ± 1.02 77.40 ± 1.10
OS 41.70 ± 0.58 14.57 ± 0.52 14.25 ± 0.56
RPE 86.23 ± 1.21 13.26 ± 0.17 12.93 ± 0.18
Abbreviations: SD (standard deviation); H (Healthy subjects group); MSON- (eyes of patients with multiple sclerosis without optic neuritis in medical
history); MSON+ (eyes of patients with multiple sclerosis with optic neuritis in medical history); GCC (ganglion cell complex. the RNFL and GCL+IPL
layers together)
* 0.001<p<0.05 and
‡ p<0.001 (Mixed-model analysis ANOVA) between H and MSON+ (see H column). H and MSON- (see MSON- column) and between MSON- and MSON
+ (see MSON+ column)
doi:10.1371/journal.pone.0143711.t002
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Table 3. Distribution statistics of the contrast (a.u) of intraretinal layers by study group, represented as means ±SD.
Contrast Healthy MSON- MSON+
H vs. MSON+ H vs. MSON- MSON+ vs MSON-
Across All Macular Regions
RNFL 1562 ± 26 ‡ 1663 ± 25 * 1820 ± 27 ‡
GCL+IPL 1531 ± 21 ‡ 1587 ± 21 1727 ± 22 ‡
GCC 3093 ± 43 ‡ 3251 ± 42 * 3546 ± 46‡
INL 1394 ± 31 ‡ 1428 ± 30 1577 ± 32 ‡
OPL 1314 ± 21 ‡ 1325 ± 20 1426 ± 21 ‡
ONL+IS 851 ± 15 862 ± 14 839 ± 15
OS 3506 ± 70 3561 ± 67 3650 ± 73
RPE 5264 ± 82 5222 ± 80 5353 ± 86
Foveolar Region
ONL+IS 881 ± 28 892 ± 27 820 ± 30
OS 3077 ± 67 3118 ± 65 3184 ± 71
RPE 7465 ± 113 7436 ± 111 7742 ± 120 *
Foveal Region
RNFL 2169 ± 88 * 2378 ± 84 2539 ± 91
GCL+IPL 2503 ± 42 ‡ 2640 ± 41 * 2935 ± 45 ‡
GCC 4673 ± 106 ‡ 5023 ± 102 * 5469 ± 111 ‡
INL 2093 ± 77 ‡ 2362 ± 75 * 2477 ± 82
OPL 2052 ± 38 2164 ± 37 2208 ± 40
ONL+IS 960 ± 21 962 ± 20 906 ± 22 *
OS 4120 ± 117 4081 ± 114 4147 ± 124
RPE 7452 ± 114 7426 ± 111 7511 ± 118
Parafoveal Region
RNFL 4122 ± 97 ‡ 4366 ± 95 4628 ± 103
GCL+IPL 1872 ± 43 ‡ 2144 ± 42 ‡ 2387 ± 46 ‡
GCC 5995 ± 120 ‡ 6516 ± 118 * 7003 ± 128 *
INL 3879 ± 51 3819 ± 50 3853 ± 54
OPL 4144 ± 52 4131 ± 51 4115 ± 55
ONL+IS 1120 ± 28 1142 ± 27 1093 ± 29
OS 4202 ± 250 4272 ± 243 4245 ± 264
RPE 8150 ± 181 8277 ± 176 8387 ± 187
Perifoveal Region
RNFL 2213 ± 44 ‡ 2429 ± 43 ‡ 2646 ± 46 ‡
GCL+IPL 1879 ± 39 ‡ 2070 ± 38 ‡ 2290 ± 41 ‡
GCC 4093 ± 79 ‡ 4499 ± 77 ‡ 4934 ± 83 ‡
INL 3511 ± 45 3425 ± 43 3477 ± 47
OPL 4038 ± 46 3928 ± 44 4005 ± 47
ONL+IS 1295 ± 27 1282 ± 25 1261 ± 27
OS 4690 ± 154 4830 ± 150 4913 ± 162
RPE 7974 ± 113 7843 ± 111 7848 ± 120
Abbreviations: SD (standard deviation); H (Healthy subjects group); MSON- (eyes of patients with multiple sclerosis without optic neuritis in medical
history); MSON+ (eyes of patients with multiple sclerosis with optic neuritis in medical history); GCC (ganglion cell complex. the RNFL and GCL+IPL
layers together)
* 0.001<p<0.05 and
‡ p<0.001 (Mixed-model analysis ANOVA) between H and MSON+ (see H column). H and MSON- (see MSON- column) and between MSON- and MSON
+ (see MSON+ column)
doi:10.1371/journal.pone.0143711.t003
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Table 4. Distribution statistics of the fractal dimension (a.u) of intraretinal layers by study group, represented as means ±SD.
Fractal dimension Healthy MSON- MSON+
H vs. MSON+ H vs. MSON- MSON+ vs MSON-
Across All Macular Regions
RNFL 1.621 ± 0.009 * 1.637 ± 0.009 1.655 ± 0.009
GCL+IPL 1.699 ± 0.002 ‡ 1.695 ± 0.002 1.690 ± 0.002 *
GCC 3.321 ± 0.008 * 3.332 ± 0.008 3.344 ± 0.008
INL 1.779 ± 0.002 ‡ 1.785 ± 0.002 * 1.788 ± 0.002
OPL 1.508 ± 0.002 * 1.502 ± 0.002 * 1.503 ± 0.002
ONL+IS 1.778 ± 0.006 1.788 ± 0.006 1.794 ± 0.006
OS 1.701 ± 0.003 * 1.712 ± 0.003 * 1.712 ± 0.004
RPE 1.669 ± 0.002 1.666 ± 0.002 1.668 ± 0.002
Foveolar Region
ONL+IS 1.718 ± 0.008 1.721 ± 0.007 1.731 ± 0.008
OS 1.730 ± 0.004 1.739 ± 0.004 1.736 ± 0.004
RPE 1.642 ± 0.001 1.641 ± 0.001 1.644 ± 0.002
Foveal Region
RNFL 2.005 ± 0.018 * 2.058 ± 0.017 * 2.075 ± 0.018
GCL+IPL 1.931 ± 0.002 1.927 ± 0.002 1.929 ± 0.002
GCC 3.937 ± 0.017 * 3.985 ± 0.016 * 4.003 ± 0.017
INL 2.018 ± 0.004 ‡ 2.031 ± 0.004 * 2.040 ± 0.004
OPL 1.480 ± 0.002 1.475 ± 0.002 1.480 ± 0.002
ONL+IS 1.757 ± 0.008 1.765 ± 0.007 1.770 ± 0.008
OS 1.711 ± 0.004 1.717 ± 0.004 1.716 ± 0.005
RPE 1.659 ± 0.002 1.657 ± 0.002 1.660 ± 0.002
Parafoveal Region
RNFL 1.447 ± 0.011 * 1.462 ± 0.011 1.492 ± 0.012 *
GCL+IPL 1.571 ± 0.003 1.568 ± 0.002 1.565 ± 0.003
GCC 3.017 ± 0.011 3.029 ± 0.010 3.057 ± 0.011 *
INL 1.670 ± 0.002 1.673 ± 0.002 1.674 ± 0.002
OPL 1.514 ± 0.002 * 1.505 ± 0.002 ‡ 1.507 ± 0.002
ONL+IS 1.785 ± 0.007 1.793 ± 0.006 1.799 ± 0.007
OS 1.699 ± 0.005 1.708 ± 0.005 1.707 ± 0.005
RPE 1.674 ± 0.002 1.672 ± 0.002 1.672 ± 0.002
Perifoveal Region
RNFL 1.461 ± 0.005 1.459 ± 0.005 1.468 ± 0.006
GCL+IPL 1.612 ± 0.002 ‡ 1.605 ± 0.002 1.598 ± 0.003 *
INL 3.072 ± 0.005 3.063 ± 0.005 3.067 ± 0.005
OPL 1.681 ± 0.002 * 1.684 ± 0.002 * 1.683 ± 0.002
ONL+IS 1.522 ± 0.002 * 1.516 ± 0.002 1.515 ± 0.002
OS 1.796 ± 0.006 * 1.808 ± 0.005 * 1.814 ± 0.006
RPE 1.692 ± 0.004 1.706 ± 0.003 1.708 ± 0.004
GCC 1.676 ± 0.002 1.673 ± 0.002 1.674 ± 0.002
Abbreviations: SD (standard deviation); H (Healthy subjects group); MSON- (eyes of patients with multiple sclerosis without optic neuritis in medical
history); MSON+ (eyes of patients with multiple sclerosis with optic neuritis in medical history); GCC (ganglion cell complex. the RNFL and GCL+IPL
layers together)
* 0.001<p<0.05 and
‡ p<0.001 (Mixed-model analysis ANOVA) between H and MSON+ (see H column). H and MSON- (see MSON- column) and between MSON- and MSON
+ (see MSON+ column)
doi:10.1371/journal.pone.0143711.t004
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Table 5. Distribution statistics of the layer index (a.u) of intraretinal layers by study group, represented asmeans ±SD.
Layer index Healthy MSON- MSON+
H vs. MSON+ H vs. MSON- MSON+ vs MSON-
Across All Macular Regions
RNFL 11.06 ± 0.25 ‡ 9.28 ± 0.25 ‡ 7.90 ± 0.27 ‡
GCL+IPL 13.49 ± 0.33 ‡ 11.32 ± 0.32 ‡ 9.84 ± 0.34 ‡
GCC 24.56 ± 0.55 ‡ 20.62 ± 0.53 ‡ 17.70 ± 0.57 ‡
INL 4.37 ± 0.13 * 3.97 ± 0.13 * 3.98 ± 0.14
OPL 6.39 ± 0.20 * 5.84 ± 0.20 5.57 ± 0.21
ONL+IS 7.49 ± 0.23 * 6.67 ± 0.22 * 6.83 ± 0.24
OS 6.05 ± 0.14 5.70 ± 0.13 5.67 ± 0.14
RPE 6.47 ± 0.08 6.55 ± 0.07 6.45 ± 0.08
Foveolar Region
ONL+IS 9.03 ± 0.32 * 7.88 ± 0.31 * 7.87 ± 0.34
OS 6.55 ± 0.13 * 6.04 ± 0.12 * 6.16 ± 0.13
RPE 7.85 ± 0.11 * 7.9 ± 0.11 * 7.67 ± 0.11
Foveal Region
RNFL 5.28 ± 0.18 * 4.82 ± 0.17 4.49 ± 0.19
GCL+IPL 13.98 ± 0.40 ‡ 12.25 ± 0.38 * 10.63 ± 0.41 ‡
GCC 19.25 ± 0.55 ‡ 17.06 ± 0.53 * 15.13 ± 0.57 *
INL 4.45 ± 0.15 4.09 ± 0.15 4.04 ± 0.16
OPL 9.19 ± 0.35 * 8.41 ± 0.34 7.59 ± 0.37
ONL+IS 8.51 ± 0.27 7.55 ± 0.26 * 7.73 ± 0.28
OS 6.38 ± 0.18 6.07 ± 0.17 6.05 ± 0.19
RPE 6.73 ± 0.09 6.81 ± 0.09 6.64 ± 0.10
Parafoveal Region
RNFL 9.22 ± 0.21 ‡ 7.92 ± 0.21 ‡ 6.86 ± 0.22 ‡
GCL+IPL 15.94 ± 0.41 ‡ 13.36 ± 0.39 ‡ 11.60 ± 0.43 ‡
GCC 25.17 ± 0.58 ‡ 21.29 ± 0.56 ‡ 18.43 ± 0.61 ‡
INL 4.83 ± 0.15 4.43 ± 0.15 4.46 ± 0.16
OPL 6.12 ± 0.22 5.61 ± 0.21 5.55 ± 0.23
ONL+IS 7.65 ± 0.24 6.84 ± 0.24 * 7.05 ± 0.26
OS 5.88 ± 0.19 5.63 ± 0.18 5.64 ± 0.20
RPE 6.24 ± 0.09 6.28 ± 0.08 6.17 ± 0.09
Perifoveal Region
RNFL 13.39 ± 0.32 ‡ 10.96 ± 0.32 ‡ 9.14 ± 0.34 ‡
GCL+IPL 12.41 ± 0.32 ‡ 10.27 ± 0.31 ‡ 8.93 ± 0.33 ‡
GCC 25.81 ± 0.60 ‡ 21.24 ± 0.57 ‡ 18.02 ± 0.62 ‡
INL 4.17 ± 0.12 * 3.79 ± 0.12 * 3.81 ± 0.13
OPL 4.86 ± 0.15 * 4.48 ± 0.14 4.45 ± 0.15
ONL+IS 6.64 ± 0.21 5.94 ± 0.21 * 6.11 ± 0.23
OS 5.83 ± 0.14 5.47 ± 0.13 5.46 ± 0.14
RPE 6.21 ± 0.08 6.33 ± 0.08 6.26 ± 0.08
Abbreviations: SD (standard deviation); H (Healthy subjects group); MSON- (eyes of patients with multiple sclerosis without optic neuritis in medical
history); MSON+ (eyes of patients with multiple sclerosis with optic neuritis in medical history); GCC (ganglion cell complex. the RNFL and GCL+IPL
layers together)
* 0.001<p<0.05 and
‡ p<0.001 (Mixed-model analysis ANOVA) between H and MSON+ (see H column). H and MSON- (see MSON- column) and between MSON- and MSON
+ (see MSON+ column)
doi:10.1371/journal.pone.0143711.t005
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Table 6. Distribution statistics of the total reflectance (dB) with compensation to RPE layer reflectance of intraretinal layers by study group, repre-
sented as means ±SD.
Total reflectance Healthy MSON- MSON+
H vs. MSON+ H vs. MSON- MSON+ vs MSON-
Across All Macular Regions
RNFL 21.52 ± 0.26 ‡ 19.90 ± 0.26 ‡ 18.54 ± 0.28 ‡
GCL+IPL 22.50 ± 0.29 ‡ 20.76 ± 0.28 ‡ 19.62 ± 0.30 ‡
GCC 45.72 ± 0.53 ‡ 42.14 ± 0.51 ‡ 39.4 ± 0.56 ‡
INL 13.03 ± 0.30 12.10 ± 0.29 * 12.17 ± 0.31
OPL 14.30 ± 0.29 * 13.52 ± 0.28 * 13.48 ± 0.30
ONL+IS 16.98 ± 0.32 15.99 ± 0.31 * 16.28 ± 0.34
OS 15.89 ± 0.21 * 15.3 ± 0.20 * 15.20 ± 0.22
RPE 16.43 ± 0.10 16.58 ± 0.09 16.45 ± 0.10
Foveolar Region
ONL+IS 19.18 ± 0.34 * 18.06 ± 0.33 * 18.05 ± 0.36
OS 16.55 ± 0.17 * 15.86 ± 0.17 * 16.00 ± 0.18
RPE 18.11 ± 0.12 18.19 ± 0.12 17.93 ± 0.13
Foveal Region
RNFL 14.87 ± 0.32 * 14.01 ± 0.31 13.41 ± 0.33
GCL+IPL 23.30 ± 0.27 ‡ 22.11 ± 0.27 * 20.92 ± 0.29 ‡
GCC 38.16 ± 0.56 ‡ 36.12 ± 0.54 * 34.33 ± 0.59 *
INL 13.29 ± 0.30 12.57 ± 0.29 12.50 ± 0.32
OPL 19.42 ± 0.36 * 18.61 ± 0.35 17.82 ± 0.38
ONL+IS 18.84 ± 0.29 17.85 ± 0.28 * 18.08 ± 0.31
OS 16.41 ± 0.25 15.99 ± 0.25 15.94 ± 0.27
RPE 16.88 ± 0.11 17.01 ± 0.11 16.82 ± 0.12
Parafoveal Region
RNFL 19.88 ± 0.26 ‡ 18.55 ± 0.25 ‡ 17.34 ± 0.27 ‡
GCL+IPL 24.58 ± 0.26 ‡ 23.05 ± 0.25 ‡ 21.80 ± 0.27 ‡
GCC 44.47 ± 0.49 ‡ 41.61 ± 0.47 ‡ 39.11 ± 0.51 ‡
INL 14.14 ± 0.28 13.44 ± 0.27 13.47 ± 0.29
OPL 16.17 ± 0.30 15.41 ± 0.29 15.35 ± 0.32
ONL+IS 18.12 ± 0.29 17.23 ± 0.29 * 17.48 ± 0.31
OS 15.86 ± 0.28 15.52 ± 0.27 15.47 ± 0.30
RPE 16.41 ± 0.11 16.5 ± 0.11 16.37 ± 0.12
Perifoveal Region
RNFL 23.20 ± 0.29 ‡ 21.34 ± 0.28 ‡ 19.83 ± 0.30 ‡
GCL+IPL 22.50 ± 0.29 ‡ 20.76 ± 0.28 ‡ 19.62 ± 0.30 ‡
GCC 45.72 ± 0.53 ‡ 42.14 ± 0.51 ‡ 39.40 ± 0.56 ‡
INL 13.03 ± 0.30 12.10 ± 0.29 * 12.17 ± 0.31
OPL 14.30 ± 0.29 * 13.52 ± 0.28 * 13.48 ± 0.30
ONL+IS 16.98 ± 0.32 15.99 ± 0.31 * 16.28 ± 0.34
OS 15.89 ± 0.21 * 15.30 ± 0.20 * 15.20 ± 0.22
RPE 16.43 ± 0.10 16.58 ± 0.09 16.45 ± 0.10
Abbreviations: SD (standard deviation); H (Healthy subjects group); MSON- (eyes of patients with multiple sclerosis without optic neuritis in medical
history); MSON+ (eyes of patients with multiple sclerosis with optic neuritis in medical history); GCC (ganglion cell complex. the RNFL and GCL+IPL
layers together)
* 0.001<p<0.05 and
‡ p<0.001 (Mixed-model analysis ANOVA) between H and MSON+ (see H column). H and MSON- (see MSON- column) and between MSON- and MSON
+ (see MSON+ column)
doi:10.1371/journal.pone.0143711.t006
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cells. The atrophy of these layers was pressumed to be related to trans-synaptic degeneration
and not the observed focal vascular inflammatory changes. [36] Interestingly, microcystic mac-
ular edema has been recently described in the INL in a small, severely impaired subset of MS
patients with an unclear etiology. [10, 40, 41] Saidha et al. described the thinning of the outer
retina additionally to the inner retinal changes using OCT image segmentation that appeared
independently of inner retinal and optic nerve pathology, suggesting a primary retinal process
in the background. [37–39] This was also supported by a small study employing adaptive optics
scanning laser ophthalmoscopy imaging where–although only in one subject with MS—the
thinning of the outer retina was suggested to be due to the cone density decrease caused by
optic neuropathy. [42]
The inner retinal changes appear to be in connection with central nervous system changes,
e.g. intracranial or brain substructure volume reduction (i.e. brain atrophy). [43–45] Therefore,
OCT may provide a possibility to better understand the neurobiological changes in neurode-
generative diseases such as MS and may help to develop both diagnostic and prognostic bio-
markers that can predict clinical progress.
Optical changes of the retina have been described earlier in glaucoma, a neurodegenerative
disease characterized by the loss of inner retinal structure that is very similar to that observed
in MS. It has been previously shown that the reflectance of the RNFL layer shows changes in
eyes with glaucoma in human patients [46, 47] and in rat eyes with elevated IOP and glaucoma,
as well. [21] According to the work of Huang et al. the thinning of the RNFL observed in a rat
model of glaucoma is preceded by reflectance changes that could be explained by the changes
in the optical properties of the extracellular and/or cytoplasmic constituents before cytostruc-
tural damage occurs. [21]
To our knowledge, this is the first report describing optical differences observed in the reti-
nal tissue of patients with MS. Additionally, we compared various optical parameters to thick-
ness in order to reveal which parameter could be the best predictor of existing pathology.
The parameters that revealed significant differences between study groups were the thick-
ness, layer index and total reflectance, mostly in eyes with MSON in the previous history, indi-
cating optical changes in the inner retina following optic neuritis. The findings of the
significant thinning of the RNFL, GCL+IPL and GCC complex in MS patients compared to
healthy and MSON+ subjects compared to MSON- patients, are in agreement with our earlier
results and the results of previous studies. [8, 37–39, 41, 48] More interestingly, there were sig-
nificant changes in the layer index and total reflectance also in the eyes without ON in the pre-
vious history. At the same time, the foveal region showed differences only with missed
significance (very small p values close to 0.001) in the RNFL, GCL+IPL and GCC layers in all
above parameters (except the fractal dimension), which may be explained by the compensation
mechanism of the OCTRIMA software that partly affects this region and uniforms the segmen-
tation of this area.
These results draw attention to the structural and optical changes in the macular area in MS
even without ON supporting the previous view of ongoing neurodegeneration also present in
the retina.[8, 43, 49, 50]
For the contrast, a significant reduction was observed only when looking at the entire macu-
lar region, between MSON+ versus healthy and MSON- eyes in the deeper inner retinal layers
(INL and OPL), although these differences were not expressed in other regions and parameters.
These previous findings suggest that atrophy stops at the level of the INL, which has been
referred as a barrier to trans-synaptic axonal degeneration.[36, 51, 52] Also, they are in agree-
ment with the view that MS is both a demyelinating and neurodegenerative disease. [48] We
observed significant difference in the contrast and fractal dimension parameters in the INL
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and OPL in the whole macular, foveal and parafoveal regions, which in partly agrees with pre-
vious reports. [37, 39, 53]
The outer retina showed no significant differences between the groups which was in con-
trast with our earlier report showing significant fractal dimension changes in diabetic patients
where, similarly, neurodegeneration was a proposed mechanism in the background of the
observed changes. [54] This could point to the fact of a different disease mechanism at the level
of the photoreceptors.
The observed differences in optical properties in our study can be related both to circula-
tional or inflammatory alterations of the inner retina. There is only little evidence about the
changes in microcirculation of the retina in MS. A recent study by Wang et al. using OCT angi-
ography showed significantly reduced flow index around the optic nerve head in eyes after
optic neuritis compared to healthy controls but no differences were shown in the parafoveal
circulation. [55] Although this may suggest that our observations were most possibly not influ-
enced by alterations in macular microcirculation, recent results also using hemodynamic infor-
mation have revealed retinal impaired microcirculation in the macular region. [53, 56–58]
Therefore, further investigation is needed to better characterize the structure-function relation-
ship in MS. On the other hand, inflammation may presumably be present also in the retina,
possibly supported by the “inside-out” theory of MS, namely the migration of autoreactive T
cells across the blood-brain barrier from the systemic circulation leading to inflammation. [55]
The blood-retina barrier is very similar to the blood-brain barrier and indeed, the histological
study by Green et al. described inflammatory cellular infiltrates surrounding retinal veins in
the connective tissue of the retinal nerve fiber layer and GCL in 29% of the relapsing remitting
and secondary progressive multiple sclerosis eyes. [36] It should be noted, however, that the
observed inflammation was more localized (i.e not in all vessels or the entire retina) than the
neurodegeneration observed which makes the direct correlation with our observed trends
questionable in terms of revealing inflammatory alterations present or not in our study data.
However, taking into account that the inner capillary network lies in the GCL and the outer
capillary network runs from the IPL to the OPL through the INL, the significant differences
observed between the study groups when analyzing reflectance and texture descriptors of the
RNFL and GCL+IPL complex should be further explored in a larger study and correlated to
microvasculature measurements (e.g. blood flow velocity and perfusion) using advanced opti-
cal imaging technologies. [55, 59, 60] Investigating these two capillary networks in relation to
structural, optical and functional measures may provide a much better insight to determine the
role of the retinal microcirculation (i.e capillaries, arterioles and venules) in the increased risk
of progression of multiple sclerosis in the presence of vascular comorbidities. [61, 62]
Our study has certain limitations, one of them being the small number of subjects included.
This study was aimed to see the possible usefulness of texture and optical property measure-
ments in MS, but further work is warranted on a larger group of patients in the future. Second,
the OCT device used in this study was time-domain OCT, which has a lower image resolution
compared to latest SD-OCT technology, but it was a standard when the study was initiated in
2010. In addition, we have previously shown a high level of repeatability for both the RNFL
and the GCL+IPL layers in our studies using OCTRIMA on TD-OCT images where the axial
range (depth range) is 2 mm, consequently the 1024 axial pixels have a spacing of 2 μm (i.e.
axial pixel resolution is 2 mm/1024) in depth. [23] Though our analysis is not affected by inter-
polation errors because the analysis was performed per ROI instead of using the standard
ETDRS maps, higher scanning speeds could permit a higher sampling density of the scanned
region, requiring a more accurate representation of the retinal structure. Third, study data
were not stratified in terms of age and disease duration for the ON+ group when compared to
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healthy subjects. We believe this does not affect our results largely as disease duration and age
were comparable in the three groups.
Although optical properties of the retinal tissue are not standardized measures for detecting
pathological changes of the retina, in contrast to thickness measurements, reflectance-based
measures are direct measures obtained from OCT images. Therefore, we expect these addi-
tional properties along with thickness information could facilitate a better diagnosis of retinal
diseases. It is also worth to note that only qualified OCT images that had signal levels above the
manufacturer recommended cutoff (i.e. SS higher than 6) and also had an SQF of 1 were used
in the analysis. In addition, signal normalization was implemented to reduce the difference in
measurements and minimize systematic technical variance and bias before assessing biological
variability in study eyes. Therefore, normalization allowed us to compare the features of all of
the images, ruling out differences in signal strength and mean background values. Also, we
have shown previously that our custom-built segmentation algorithm provides comparable
results to those obtained by SD-OCT and therefore we expect the trends reported here to be
replicated by advanced OCT devices. [41] Further studies are warranted.
Conclusion
In summary, it seems that texture and optical properties of the retina derived from OCT
images may provide a useful additional tool in the hands of clinicians for the assessment of
neurodegeneration and neuronal loss-related changes occurring in MS. This may help the bet-
ter differentiation of eyes with ON and more precise targeting of potential therapeutic inter-
ventions and could also be useful in the follow-up of MS patients. However, in order to prove
this, a larger set of patients needs to be involved taking advantage of state-of-the art imaging
technology and segmentation procedures.
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